Antibiotic allergy
2018 · The Lancet · 559 citations
https://doi.org/10.1016/s0140-6736(18)32218-9
J
Jonny Peter
Citigroup(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
303
Papers
10.1K
Citations
52
h-index
116
i10-index
Jonny Peter is an academic researcher from Citigroup. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Drug-Induced Adverse Reactions & Urticaria and Related Conditions. The author has an h-index of 52, co-authored 258 publications.
ORCID: 0000-0002-2658-0723Papers by this author
worksThe international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
2022 · Allergy · 457 citations
https://doi.org/10.1111/all.15214
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
2022 · The Lancet Respiratory Medicine · 289 citations
https://doi.org/10.1016/s2213-2600(22)00092-3
The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study
2020 · EClinicalMedicine · 221 citations
https://doi.org/10.1016/j.eclinm.2020.100570
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
2022 · World Allergy Organization Journal · 146 citations
https://doi.org/10.1016/j.waojou.2022.100627
Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments
2014 · Scientific Reports · 120 citations
https://doi.org/10.1038/srep05658
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat